Article
VEXAS: where do we stand 2 years later?
Current opinion in hematology - 1 Mar 2023
Sujobert Pierre, Heiblig Maël, Jamilloux Yvan
Abstract excerpt
PURPOSE OF REVIEW: Two years after the recognition of VEXAS (for Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome, we propose an extensive review of the current understanding of VEXAS pathophysiology and therapeutic options. RECENT FINDINGS: Among the nearly 150 articles published about VEXAS, some have provided determinant insights into VEXAS pathophysiology and treatment. Clinical data from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
